{
    "organizations": [],
    "uuid": "4e0dfaccf86572ac6a17b2241a8e0091d62a2003",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-amag-reports-q4-earnings-of-010-pe/brief-amag-reports-q4-earnings-of-0-10-per-share-idUSASB0C7NR",
    "ord_in_thread": 0,
    "title": "BRIEF-AMAG Reports Q4 Earnings Of $0.10 Per Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Amag Pharmaceuticals Inc:\n* AMAG REPORTS 2017 FINANCIAL RESULTS AND COMPANY UPDATE * Q4 EARNINGS PER SHARE $0.10 * TOTAL GAAP REVENUES FOR Q4 OF 2017 WERE $158.3 MILLION, COMPARED WITH $151.6 MILLION\n* NON-GAAP REVENUE TOTALED $159.7 MILLION IN Q4 OF 2017, UP FROM $153.0 MILLION\n* SAYS AFFIRMS FINANCIAL GUIDANCE FOR 2018 * QUARTERLY TOTAL REVENUES $158.3 MILLION VERSUS $151.6 MILLION Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)\n ",
    "published": "2018-02-27T20:14:00.000+02:00",
    "crawled": "2018-02-28T13:18:18.014+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "amag",
        "pharmaceutical",
        "inc",
        "amag",
        "report",
        "financial",
        "result",
        "company",
        "update",
        "q4",
        "earnings",
        "per",
        "share",
        "total",
        "gaap",
        "revenue",
        "q4",
        "million",
        "compared",
        "million",
        "revenue",
        "totaled",
        "million",
        "q4",
        "million",
        "say",
        "affirms",
        "financial",
        "guidance",
        "quarterly",
        "total",
        "revenue",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "bengaluru",
        "newsroom"
    ]
}